Coronavirus vaccines from Pfizer and Moderna are based on messenger RNA technology that could transform the way science fights diseases.

Though messenger RNA technology like Pfizer, Moderna use hasn't grabbed headlines before now, some researchers have been working on it for decades.

As the world grapples with yet another variant of concern in the global COVID-19 pandemic, a new study shows how Pfizer-BioNTech's messenger RNA vaccine helps the immune system remember pathogens ...

The Pfizer-BioNTech and Moderna messenger RNA vaccines for COVID-19 are authorized for emergency use in the U.S.

Just 8 weeks after it authorized booster doses of the Pfizer-BioNTech COVID-19 vaccine for people at high risk for severe disease, the FDA on Thursday announced that any adult is now eligible for ...

The Pfizer-BioNTech and Moderna messenger RNA vaccines for COVID-19 are authorized for emergency use in the U.S.

Researchers observed more than 35,000 women in the study. Messenger RNA vaccines for COVID-19, such as those produced by Moderna and Pfizer, showed no obvious safety concerns for pregnant women ...

Now that its Pfizer-partnered COVID-19 vaccine has been delivered to hundreds of millions of people globally, BioNTech is ready to hit go on the second-most advanced candidate in its pipeline.

Drugmakers big and small are storming into messenger RNA research. The technology behind the first COVID-19 vaccines could help fight other diseases, including cancer. Early leaders in the mRNA ...

A local researcher from Penn Medicine says there's reason to believe at least one other potential coronavirus vaccine could be as effective as Pfizer's vaccine is said to be.

The CDC’s Advisory Committee on Immunization Practices on Wednesday agreed with CDC staff recommendations that myocarditis risks in young people associated with messenger RNA-based COVID-19 ...